Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Jung, Jae Hung; McCutcheon, Karen; Reddy, Balaji; Borofsky, Michael S.; Narayan, Vikram M.; Kim, Myung Ha; Dahm, Philipp

doi:10.1002/14651858.cd012832

Cited by 18 publications

(11 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…While including nine surgical treatment approaches, 109 trials, and 13 376 study participants, this review did not include the latest additions to the treatment armamentarium that were the focus of our review. Three relevant Cochrane reviews have been published, each focusing on single treatment modalities, namely, for PUL [21] , Aquablation [22] , and Rezūm [23] . For PUL with follow-up up to 24 mo, the review found that PUL may be less effective in relieving urinary symptoms but results in similar QoL.…”

Section: Evidence Synthesismentioning

confidence: 99%

“…PUL may preserve ejaculation and have fewer unwanted effects on erections than TURP. The authors further stated that there was uncertainty or no evidence about serious unwanted side effects or the need for additional treatment after surgery [21] . For Aquablation and based on limited follow-up up to 12 mo, the authors found that the effect on urological symptoms and QoL was probably similar to that of TURP.…”

Section: Evidence Synthesismentioning

confidence: 99%

See 1 more Smart Citation

Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia

Dahm

MacDonald

McKenzie

et al. 2021

European Urology Open Science

Self Cite

View full text Add to dashboard Cite

Context Several newer device-based procedures have recently become available for treating men with lower urinary tract symptoms attributed to benign prostatic hyperplasia, but their effectiveness remains uncertain. Objective To assess the longer-term comparative effectiveness (defined as >12 mo of follow-up) of the newer treatment modalities prostatic urethral lift (PUL), transurethral prostate convective radiofrequency water vapor (Rezūm), Aquablation, and prostatic arterial embolization (PAE). Evidence acquisition Ovid Medline, the Cochrane Central Register of Controlled Trials (CENTRAL), and the Agency for Healthcare Research and Quality databases were searched through September 30, 2019; hand searches of references of relevant studies were also performed. Eligible studies were randomized controlled trials (RCTs) published in English language. We excluded observational studies. Evidence synthesis One RCT ( n = 91) found that patients undergoing PUL may be less likely to respond (risk ratio [RR] 0.8; 95% confidence interval [CI] 0.7–1.0; low certainty of evidence [CoE]) and have a higher mean International Prostate Symptom Score (IPSS; mean difference 6.1; 95% CI 2.2–10.0; low CoE) than those undergoing transurethral resection of the prostate (TURP). Among patients undergoing PAE, one small RCT ( n = 30) reported similar IPSS response rates (RR 0.9; 95% CI 0.7–1.1; low CoE) and one trial ( n = 107) found similar mean IPSS (–0.7; 95% CI –1.3 to 2.7; moderate CoE) scores to those among patients undergoing TURP. A single study on Aquablation reported 12 mo of follow-up only, and a single 3-mo trial compared Rezūm with sham treatment. Conclusions The current best evidence underlying these newer therapies is limited to few trials (PUL and PAE), short-term follow-up of 12 mo (Aquablation and Rezūm), or sham comparison only (Rezūm). Patient summary Evidence for four of the newer surgical treatments for men with an enlarged prostate is limited to few small trials with short-term follow-up; only one trial compared a new treatment modality with sham surgery.

show abstract

Section: Evidence Synthesismentioning

confidence: 99%

Section: Evidence Synthesismentioning

confidence: 99%

Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia

Dahm

MacDonald

McKenzie

et al. 2021

European Urology Open Science

Self Cite

View full text Add to dashboard Cite

show abstract

“…Основываясь на анализе десяти статей с шестью независимыми когортами пациентов, можно сделать вывод о хорошей переносимости и малой инвазивности данного метода, а также благоприятных результатах до 12 месяцев наблюдения. Во всех исследованиях отмечается положительное влиянии на эректильную и эякуляторную функцию в сравнении с более инвазивными трансуретральными вмешательствами [43]…”

Section: сравнительная характеристика современных методов хирургического лечения доброкачественной гиперплазии предстательной железы (литunclassified

Comparative characteristics of modern methods of surgical treatment of benign prostate hyperplasia (literature review)

Filimonov¹,

Vasin²,

Sobennikov³

et al. 2021

HMJ

View full text Add to dashboard Cite

The article presents an overview of modern domestic and foreign literature, dedicated to the problem of surgical treatment of benign prostatic hyperplasia. There exists a wide range of approaches to surgical treatment of benign prostatic hyperplasia. A decision in favor of a certain method is individual and takes into account somatic status of the patient, peculiarities of growth of adenoma and the volume of prostate. In the article, a general tendency of using different endourologic interventions is emphasized. In case of moderate dimensions of the prostate the preferable methods are endoscopic enucleation, transurethral resection and photoselective vaporization of the prostate that are comparable in terms of functional, morphological parameters and duration of recovery period. However, application of non-invasive transurethral interventions in case of the gland volume more than 80 cm3 is limited and requires further improvement of surgical technique. Aquablation, transurethral microwave thermotherapy are promising methods requiring further independent randomized studies.

show abstract

“…In today's era, with the availability of numerous minimally invasive procedures to treat BPH, the findings of this Cochrane Review will be highly relevant to policymakers, healthcare providers and patients alike. We expect this review to complement a suite of related Cochrane Reviews focused on the endourological management (Jung 2017a) and vascular management (Jung 2017b) of LUTS related to BPH.…”

Section: Why It Is Important To Do This Reviewmentioning

confidence: 99%

“…Direct comparisons, for example of Aquablation and the water vapour thermal therapy would be helpful to compare their comparative e ectiveness. Cochrane Reviews for other relevant procedures are ongoing (Kang 2019;Jung 2017a;Jung 2017b;Mamoulakis 2014).…”

Section: Overall Completeness and Applicability Of Evidencementioning

confidence: 99%

Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Hwang

Jung

Borofsky

et al. 2019

Cochrane Database of Systematic Reviews

Self Cite

View full text Add to dashboard Cite

show abstract

Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Abstract: , P. (2017). Prostatic urethral lift for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia (Protocol). Cochrane database of systematic reviews (Online), 1-17. [CD012832.].

Cited by 18 publications

References 39 publications

Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia

Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia

Comparative characteristics of modern methods of surgical treatment of benign prostate hyperplasia (literature review)

Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Contact Info

Product

Resources

About